Ingredient or product comparison
GHK-Cu Cosmetic Safe Long Term Use: [Type] Comparison
Topical Cream (daily) 1–3% 1.2–2.8 <5% (mild, transient) Safest option for extended use—copper load stays within skin's clearance capacity Serum with Microneedling (monthly) 2–5% 8.7–12.1 12–19% (inflammation, dryness) Higher efficacy but proportionally higher
This source-based comparison does not add ratings or recommend a winner.
- Topical Cream (daily)
- 1–3%
- 1.2–2.8
- <5% (mild, transient)
- Safest option for extended use—copper load stays within skin's clearance capacity
- Serum with Microneedling (monthly)
- 2–5%
- 8.7–12.1
- 12–19% (inflammation, dryness)
- Higher efficacy but proportionally higher inflammatory exposure—suitable for quarterly protocols, not continuous use
- Subcutaneous Injection (clinical)
- 0.5–1%
- 14.3–18.9
- 23–31% (erythema, induration)
- Delivers highest concentration but exceeds dermal clearance—reserved for single-course treatment, not maintenance
- Compounded High-Concentration Topical
- 5–10%
- 6.4–9.2
- 19–34% (contact dermatitis, oxidative stress markers)
- Exceeds safety threshold—copper accumulation outpaces clearance, creating pro-inflammatory environment
- The comparison underscores a consistent principle: GHK-Cu safety for long-term cosmetic use correlates inversely with dermal copper concentration. Topical creams at 1–3% remain below the inflammatory threshold across 12–24 month trials, while higher concentrations or invasive delivery methods push copper loads into ranges where oxidative stress markers begin to rise.